Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

BioLife Sciences Inc. (BLFE)

Other OTC - Other OTC Delayed Price. Currency in USD
0.0100-0.0005 (-4.31%)
At close: 12:33PM EST
Advertisement
Full screen
Loading interactive chart...
  • GlobeNewswire

    BioLife Sciences Inc. (OTC:PK BLFE) is Pleased to Announce Its Q1 2023 Slated Release of Its Copper-Infused Fabric Pot Prototype

    HENDERSON NV, Nov. 22, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – MFusion infuses copper metal ions directly into every sub-bundle of fabric, allowing for 100% copper coverage. The majority of copper textile products currently in the marketplace offer as little as 5% copper coverage. The Company’s first copper-infused prototype will leverage the natural antimicrobial benefits of copper ions, which have been shown to kill 99.99% of harmful bacteria and viruses. Copper ions are proven pathogen ki

  • GlobeNewswire

    BioLife Sciences Inc. Seeks to Retain an Auditing and Consulting Services Firm

    HENDERSON, NV, Nov. 03, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioLife Sciences Inc. (“BioLife” or the “Company”) (OTCPK: BLFE) announced that it is seeking to retain an auditing and consulting services firm with specific expertise with SEC filings, to assist with the pursuit of becoming fully reporting with sights set on up-listing to the Over-the-Counter Quotation Bureau (“OTCQB”). Nika Jaksic, COO of Bio Life Sciences Inc., stated, “We are excited to announce this important next step, th

  • GlobeNewswire

    BioLife Sciences Inc. (OTC: BLFE) Enters Into Negotiations for Exclusive Licensing Deal With Canadian Firm

    HENDERSON, NV, Sept. 26, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioLife Sciences (OTCPK: BLFE) is pleased to announce that it has entered into negotiations with Canadian Firm--Work In Motion towards the development and commercialization of custom designed copper infused bamboo gardening gloves for international distribution through Work In Motion’s extensive wholesale and distribution networks. BioLife Sciences is contemplated to assume sole responsibility for the development and commercial

Advertisement
Advertisement